Richard Bernstein Advisors LLC Moderna, Inc. Transaction History

Richard Bernstein Advisors LLC

  • $4.64 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$118.38 - $210.04 $1.65 Million - $2.92 Million
13,919 New
13,919 $2.5 Million
Q1 2022

May 12, 2022
SELL
$126.46 - $235.05 $1.33 Million - $2.47 Million
-10,517 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$225.82 - $368.51 $2.37 Million - $3.88 Million
10,517 New
10,517 $2.67 Million

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Richard Bernstein Advisors LLC Portfolio

Follow Richard Bernstein Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richard Bernstein Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email